HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.

Abstract
Alport syndrome is a hereditary type IV collagen disease leading to progressive renal fibrosis, hearing loss and ocular changes. End stage renal failure usually develops during adolescence. COL4A3-/- mice serve as an animal model for progressive renal scarring in Alport syndrome. The present study evaluates the role of Discoidin Domain Receptor 1 (DDR1) in cell-matrix interaction involved in pathogenesis of Alport syndrome including renal inflammation and fibrosis. DDR1/COL4A3 Double-knockouts were compared to COL4A3-/- mice with 50% or 100% expression of DDR1, wildtype controls and to DDR1-/- COL4A3+/+ controls for over 6years. Double-knockouts lived 47% longer, mice with 50% DDR1 lived 29% longer and showed improved renal function (reduction in proteinuria and blood urea nitrogen) compared to animals with 100% DDR1 expression. Loss of DDR1 reduced proinflammatory, profibrotic cells via signaling of TGFbeta, CTGF, NFkappaB and IL-6 and decreased deposition of extracellular matrix. Immunogold-staining and in-situ hybridisation identified podocytes as major players in DDR1-mediated fibrosis and inflammation within the kidney. In summary, glomerular epithelial cells (podocytes) express DDR1. Loss of DDR1-expression in the kidney delayed renal fibrosis and inflammation in hereditary type IV collagen disease. This supports our hypothesis that podocyte-matrix interaction via collagen receptors plays an important part in progression of renal fibrosis in Alport disease. The blockade of collagen-receptor DDR1 might serve as an important new therapeutic concept in progressive fibrotic and inflammatory diseases in the future.
AuthorsOliver Gross, Rainer Girgert, Bogdan Beirowski, Matthias Kretzler, Hee Gyung Kang, Jenny Kruegel, Nicolai Miosge, Ann-Christin Busse, Stephan Segerer, Wolfgang F Vogel, Gerhard-Anton Müller, Manfred Weber
JournalMatrix biology : journal of the International Society for Matrix Biology (Matrix Biol) Vol. 29 Issue 5 Pg. 346-56 (Jun 2010) ISSN: 1569-1802 [Electronic] Netherlands
PMID20307660 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2010 Elsevier B.V. All rights reserved.
Chemical References
  • CCN2 protein, mouse
  • CD3 Complex
  • Collagen Type IV
  • NF-kappa B
  • Transforming Growth Factor beta
  • Connective Tissue Growth Factor
  • RNA
  • Urea
  • Ddr1 protein, mouse
  • Discoidin Domain Receptor 1
  • Receptor Protein-Tyrosine Kinases
Topics
  • Animals
  • CD3 Complex (metabolism)
  • Collagen Type IV (genetics, metabolism)
  • Connective Tissue Growth Factor (metabolism)
  • Discoidin Domain Receptor 1
  • Female
  • Fibrosis (metabolism, physiopathology)
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Kidney Glomerulus (metabolism, physiopathology, ultrastructure)
  • Longevity
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mice, Knockout
  • Microscopy, Electron
  • NF-kappa B (metabolism)
  • Nephritis, Hereditary (metabolism, physiopathology)
  • Proteinuria (metabolism)
  • RNA (chemistry, genetics)
  • Receptor Protein-Tyrosine Kinases (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta (metabolism)
  • Urea (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: